IMMU - Immunomedics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/20186/30/20186/30/20176/30/2016
Total Revenue-2,1563,0913,233
Cost of Revenue187,77499,89652,25954,651
Gross Profit-187,774-97,740-49,168-51,418
Operating Expenses
Research Development----
Selling General and Administrative101,29643,30723,0827,590
Non Recurring----
Others----
Total Operating Expenses289,070143,20375,34162,241
Operating Income or Loss-289,070-141,047-72,250-59,008
Income from Continuing Operations
Total Other Income/Expenses Net-26,428-132,684-80,996-5,182
Earnings Before Interest and Taxes-289,070-141,047-72,250-59,008
Interest Expense-40,034-23,255-5,480-5,480
Income Before Tax-315,498-273,731-153,246-64,190
Income Tax Expense-15620-5,054
Minority Interest-902-821-771-710.74
Net Income From Continuing Ops-315,498-273,887-153,266-59,136
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-315,336-273,837-153,206-59,037
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-315,336-273,837-153,206-59,037